No Pharma Money
News & Reports
News July 9, 2021

President Biden’s Executive Order Drives Competition To Lower Drug Prices, The Administration Reaffirms Its Support For Legislation To Allow Medicare To Negotiate

By P4ADNow Team

WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now, in response to President Biden’s July 9 Executive Order on Promoting Competition in the American Economy:

“We applaud President Biden for promoting competition to drive true innovation and lower prescription drug prices for Americans. This executive order is another demonstration of the administration’s commitment to providing relief to patients struggling to afford their prescription medications. We look forward to working with HHS and the FTC as they craft their plans to fulfill the requests in the order.
 
“The president’s executive order included a restatement of his call for comprehensive legislation, including allowing Medicare to negotiate lower drug prices. Both avenues — executive action and legislative solutions — can contribute to the reforms we need to ensure we get the innovation we need at prices patients can afford.”

###

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.